Lymphoma

Top Story

Biden Cancer Initiative seeks to inject urgency into cancer research, foster hope for patients

Biden Cancer Initiative seeks to inject urgency into cancer research, foster hope for patients
June 26, 2017

Former Vice President Joe Biden and his wife, Jill Biden, PhD, launched the Biden Cancer Initiative today.

The venture is intended to further progress in cancer prevention, detection, treatment and care, while reducing disparities in patient outcomes.

Brentuximab vedotin shows promise in frontline chemotherapy regimen for Hodgkin lymphoma

June 26, 2017
The phase 3 trial designed to evaluate brentuximab vedotin as part of a frontline chemotherapy regimen for previously untreated advanced classical Hodgkin lymphoma met…
In the Journals

Clonal hematopoiesis of indeterminate potential increases CHD risk

June 26, 2017
Patients who have clonal hematopoiesis of indeterminate potential in peripheral blood cells had an elevated risk for CHD, according to a study published in The New

Novel approach may prolong remission after T-cell immunotherapy for leukemia, lymphoma

June 26, 2017
Researchers at Seattle Children’s Hospital have launched a first-in-human trial to investigate whether infusions of T-cell antigen–presenting cells prolong…
CME

Combination Strategies in Melanoma Management: What’s New and What’s Next

This activity is supported by an educational grant from Genentech, Inc.

Melanoma is the sixth most common cancer in the United States and the deadliest form of skin cancer. Although it is…
More »
Video
Meeting News Coverage

VIDEO: GALLIUM study will change care for some patients with follicular lymphoma

December 19, 2016
More »
Featured

CME

Immune Checkpoint Inhibitors for Advanced Melanoma: Clinical Updates and Multidisciplinary Strategies

This activity is supported by an educational grant from Bristol-Myers Squibb.

Incidence rates of melanoma in the United States continue to rise, with an estimated 87,110 new cases being diagnosed…
More »

Biden Cancer Initiative seeks to inject urgency into cancer research, foster hope for patients

June 26, 2017
Former Vice President Joe Biden and his wife, Jill Biden, PhD, launched the Biden Cancer Initiative today. The venture is intended to further…

Brentuximab vedotin shows promise in frontline chemotherapy regimen for Hodgkin lymphoma

June 26, 2017
The phase 3 trial designed to evaluate brentuximab vedotin as part of a frontline chemotherapy regimen for previously untreated advanced classical…

In the Journals

Clonal hematopoiesis of indeterminate potential increases CHD risk

June 26, 2017
Patients who have clonal hematopoiesis of indeterminate potential in peripheral blood cells had an elevated risk for CHD, according to a study…

Novel approach may prolong remission after T-cell immunotherapy for leukemia, lymphoma

June 26, 2017
Researchers at Seattle Children’s Hospital have launched a first-in-human trial to investigate whether infusions of T-cell…

10 updates in immunotherapy research

June 23, 2017
In recognition of Cancer Immunotherapy Month, Cancer Research Institute has organized a series of educational and social events designed to raise…

FDA News

FDA approves Rituxan Hycela subcutaneous injection for blood cancers

June 22, 2017
The FDA approved Rituxan Hycela subcutaneous injection to treat three blood cancers. Rituxan Hycela (Genentech) — a combination of rituximab…

Meeting NewsVideo

VIDEO: Entospletinib shows promise for advanced lymphoma

June 22, 2017
CHICAGO — Entospletinib appeared safe for patients with relapsed or refractory lymphoplasmacytoid lymphoma, according to study results…

FDA News

FDA grants orphan drug designation to tazemetostat for soft tissue sarcoma

June 21, 2017
The FDA granted orphan drug designation to tazemetostat for the treatment of patients with soft tissue sarcoma, according to the drug’s…

Geneticist to lead Vanderbilt cancer center’s health disparities program

June 19, 2017
Tuya Pal, MD, has been appointed associate director of cancer health disparities at Vanderbilt-Ingram Cancer Center. Pal, a clinical geneticist…

Meeting NewsVideo

VIDEO: CD19–directed CAR T cells shows promise in advanced lymphomas

June 18, 2017
CHICAGO — Treatment with JCAR017 showed promise in patients with heavily pretreated relapsed or refractory diffuse large B-cell lymphoma…

More Headlines »
Advertisement
Advertisement